| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.925 | 0.003 | 0.925 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.77 0.004 DBMET01854 0.232 0.014 DBMET01855 0.724 0.004 DBMET01856 | ||
| 0.911 | 0.003 | 0.911 | Raf kinase inhibitor | 0.731 0.003 DBMET01854 0.169 0.016 DBMET01855 0.677 0.004 DBMET01856 | ||
| 0.893 | 0.002 | 0.893 | Raf kinase B inhibitor | 0.679 0.003 DBMET01854 0.135 0.016 DBMET01855 0.622 0.004 DBMET01856 | ||
| 0.834 | 0.001 | 0.834 | MAP kinase kinase 4 inhibitor | 0.711 0.001 DBMET01854 0.31 0.004 DBMET01855 0.723 0.001 DBMET01856 | ||
| 0.699 | 0.002 | 0.699 | Raf kinase C inhibitor | 0.635 0.003 DBMET01854 0.231 0.007 DBMET01855 0.595 0.003 DBMET01856 | ||
| 0.697 | 0.004 | 0.697 | Growth factor agonist | 0.602 0.004 DBMET01854 0.433 0.005 DBMET01855 0.608 0.004 DBMET01856 | ||
| 0.65 | 0.001 | 0.65 | MAP kinase kinase 9 inhibitor | 0.251 0.004 DBMET01854 0.065 0.025 DBMET01855 0.262 0.004 DBMET01856 | ||
| 0.65 | 0.003 | 0.65 | Stem cell growth factor agonist | 0.515 0.004 DBMET01854 0.228 0.007 DBMET01855 0.527 0.004 DBMET01856 | ||
| 0.537 | 0.004 | 0.537 | MAP kinase kinase 10 inhibitor | 0.398 0.004 DBMET01854 0.179 0.007 DBMET01855 0.438 0.004 DBMET01856 | ||
| 0.488 | 0.003 | 0.488 | MAP kinase kinase inhibitor | 0.436 0.004 DBMET01854 0.203 0.027 DBMET01855 0.442 0.004 DBMET01856 | ||
| 0.456 | 0.007 | 0.483 | MAP kinase kinase 2 inhibitor | 0.483 0.005 DBMET01854 0.198 0.083 DBMET01855 0.42 0.01 DBMET01856 | DBMET01854 | |
| 0.393 | 0.056 | 0.492 | Angiogenesis inhibitor | 0.472 0.035 DBMET01854 0.39 0.057 DBMET01855 0.492 0.031 DBMET01856 | DBMET01856 | |
| 0.294 | 0.039 | 0.422 | Death-associated protein kinase 3 inhibitor | 0.237 0.057 DBMET01854 0.422 0.014 DBMET01855 0.247 0.053 DBMET01856 | DBMET01855 | |
| 0.266 | 0.031 | 0.358 | LIM domain kinase 1 inhibitor | 0.264 0.032 DBMET01854 0.358 0.011 DBMET01855 0.331 0.015 DBMET01856 | DBMET01855 | |
| 0.266 | 0.038 | 0.435 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.281 0.033 DBMET01854 0.435 0.008 DBMET01855 0.287 0.031 DBMET01856 | DBMET01855 | |
| 0.208 | 0.008 | 0.249 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.244 0.005 DBMET01854 0.176 0.01 DBMET01855 0.249 0.005 DBMET01856 | DBMET01856 | |
| 0.245 | 0.047 | 0.507 | CDC-like kinase 2 inhibitor | 0.303 0.031 DBMET01854 0.507 0.005 DBMET01855 0.313 0.028 DBMET01856 | DBMET01855 | |
| 0.221 | 0.044 | 0.378 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.271 0.032 DBMET01854 0.378 0.01 DBMET01855 0.307 0.024 DBMET01856 | DBMET01855 | |
| 0.183 | 0.023 | 0.249 | MAP kinase kinase kinase inhibitor | 0.249 0.01 DBMET01854 0.104 0.063 DBMET01855 0.194 0.02 DBMET01856 | DBMET01854 | |
| 0.217 | 0.065 | 0.327 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.285 0.04 DBMET01854 0.327 0.029 DBMET01855 0.301 0.036 DBMET01856 | DBMET01855 | |
| 0.168 | 0.02 | 0.208 | Protein kinase A inhibitor | 0.208 0.013 DBMET01854 0.199 0.014 DBMET01855 0.193 0.015 DBMET01856 | DBMET01854 | |
| 0.168 | 0.045 | 0.27 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.206 0.016 DBMET01854 0.27 0.005 DBMET01855 0.219 0.011 DBMET01856 | DBMET01855 | |
| 0.149 | 0.033 | 0.217 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.208 0.021 DBMET01854 0.217 0.02 DBMET01856 | DBMET01856 | |
| 0.168 | 0.057 | 0.212 | Protein kinase (CK1) gamma 1 inhibitor | 0.161 0.061 DBMET01854 0.212 0.038 DBMET01855 0.183 0.049 DBMET01856 | DBMET01855 | |
| 0.178 | 0.074 | 0.316 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.248 0.046 DBMET01854 0.316 0.032 DBMET01855 0.272 0.039 DBMET01856 | DBMET01855 | |
| 0.111 | 0.018 | 0.24 | I kappa B kinase 1 inhibitor | 0.178 0.007 DBMET01854 0.24 0.005 DBMET01855 0.193 0.005 DBMET01856 | DBMET01855 | |
| 0.172 | 0.079 | 0.307 | Tyrosine kinase inhibitor | 0.301 0.043 DBMET01854 0.307 0.042 DBMET01855 0.287 0.045 DBMET01856 | DBMET01855 | |
| 0.147 | 0.055 | 0.182 | Aurora-C kinase inhibitor | 0.159 0.04 DBMET01854 0.182 0.026 DBMET01855 0.152 0.048 DBMET01856 | DBMET01855 | |
| 0.136 | 0.047 | 0.198 | Cyclin-dependent kinase 1 inhibitor | 0.198 0.027 DBMET01854 0.104 0.064 DBMET01855 0.128 0.051 DBMET01856 | DBMET01854 | |
| 0.129 | 0.048 | 0.193 | MAP kinase 13 inhibitor | 0.193 0.023 DBMET01854 0.103 0.076 DBMET01855 0.171 0.028 DBMET01856 | DBMET01854 | |
| 0.217 | 0.138 | 0.342 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.327 0.047 DBMET01854 0.325 0.048 DBMET01855 0.342 0.04 DBMET01856 | DBMET01856 | |
| 0.164 | 0.09 | 0.439 | CDC-like kinase 4 inhibitor | 0.236 0.051 DBMET01854 0.439 0.011 DBMET01855 0.246 0.047 DBMET01856 | DBMET01855 | |
| 0.131 | 0.057 | 0.168 | MAP kinase 12 inhibitor | 0.168 0.033 DBMET01854 0.135 0.054 DBMET01855 0.163 0.035 DBMET01856 | DBMET01854 | |
| 0.072 | 0.011 | 0.072 | Alpha 1b adrenoreceptor agonist | |||
| 0.095 | 0.037 | 0.353 | Rho-associated kinase inhibitor | 0.191 0.013 DBMET01854 0.353 0.005 DBMET01855 0.173 0.015 DBMET01856 | DBMET01855 | |
| 0.16 | 0.103 | 0.655 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.295 0.044 DBMET01854 0.655 0.005 DBMET01855 0.32 0.037 DBMET01856 | DBMET01855 | |
| 0.161 | 0.104 | 0.441 | Clk dual-specificity kinase inhibitor | 0.264 0.049 DBMET01854 0.441 0.013 DBMET01855 0.331 0.031 DBMET01856 | DBMET01855 | |
| 0.114 | 0.064 | 0.114 | CDK3/cyclin E inhibitor | |||
| 0.088 | 0.039 | 0.2 | Rho-associated kinase I inhibitor | 0.149 0.014 DBMET01854 0.2 0.009 DBMET01855 0.111 0.025 DBMET01856 | DBMET01855 | |
| 0.057 | 0.013 | 0.124 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.092 0.005 DBMET01854 0.124 0.004 DBMET01856 | DBMET01856 | |
| 0.081 | 0.038 | 0.081 | Prostaglandin-E synthase inhibitor | 0.071 0.047 DBMET01854 0.076 0.042 DBMET01855 0.064 0.058 DBMET01856 | ||
| 0.067 | 0.026 | 0.067 | Bromodomain-containing protein 4 inhibitor | |||
| 0.044 | 0.006 | 0.044 | Alpha 1a adrenoreceptor agonist | |||
| 0.123 | 0.087 | 0.182 | Protein kinase (CK1) gamma inhibitor | 0.15 0.067 DBMET01854 0.182 0.051 DBMET01855 0.164 0.06 DBMET01856 | DBMET01855 | |
| 0.093 | 0.057 | 0.168 | CDK/cyclin complex inhibitor | 0.168 0.025 DBMET01854 | DBMET01854 | |
| 0.05 | 0.015 | 0.05 | Glycine transporter 1 inhibitor | |||
| 0.073 | 0.042 | 0.073 | Vanilloid 1 antagonist | |||
| 0.096 | 0.067 | 0.217 | Cyclin-dependent kinase 9 inhibitor | 0.217 0.019 DBMET01854 0.166 0.03 DBMET01855 0.181 0.026 DBMET01856 | DBMET01854 | |
| 0.076 | 0.047 | 0.239 | Janus tyrosine kinase 3 inhibitor | 0.105 0.031 DBMET01854 0.239 0.008 DBMET01855 0.112 0.029 DBMET01856 | DBMET01855 | |
| 0.093 | 0.066 | 0.147 | MAP kinase kinase 1 inhibitor | 0.136 0.023 DBMET01854 0.113 0.042 DBMET01855 0.147 0.018 DBMET01856 | DBMET01856 | |
| 0.056 | 0.029 | 0.056 | Vanilloid 2 antagonist | |||
| 0.128 | 0.104 | 0.128 | Pregnane X receptor agonist | |||
| 0.118 | 0.095 | 0.236 | Protein kinase C nu inhibitor | 0.187 0.052 DBMET01854 0.236 0.037 DBMET01855 0.199 0.048 DBMET01856 | DBMET01855 | |
| 0.06 | 0.038 | 0.089 | CDK4/cyclin D inhibitor | 0.089 0.018 DBMET01854 | DBMET01854 | |
| 0.062 | 0.044 | 0.098 | CDK1/cyclin B inhibitor | 0.098 0.025 DBMET01854 0.068 0.04 DBMET01856 | DBMET01854 | |
| 0.067 | 0.051 | 0.067 | Elastase 1 inhibitor | |||
| 0.121 | 0.106 | 0.451 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.263 0.023 DBMET01854 0.451 0.005 DBMET01855 0.327 0.011 DBMET01856 | DBMET01855 | |
| 0.076 | 0.061 | 0.09 | MAP kinase 7 inhibitor | 0.089 0.021 DBMET01854 0.09 0.019 DBMET01856 | DBMET01856 | |
| 0.059 | 0.045 | 0.084 | Cyclin B1 inhibitor | 0.084 0.019 DBMET01854 0.074 0.028 DBMET01855 0.073 0.028 DBMET01856 | DBMET01854 | |
| 0.069 | 0.056 | 0.25 | MAP kinase 14 inhibitor | 0.194 0.012 DBMET01854 0.25 0.008 DBMET01856 | DBMET01856 | |
| 0.053 | 0.042 | 0.078 | Cyclin B2 inhibitor | 0.078 0.016 DBMET01854 0.067 0.024 DBMET01855 0.067 0.024 DBMET01856 | DBMET01854 | |
| 0.092 | 0.086 | 0.178 | Polo-like kinase-4 inhibitor | 0.118 0.058 DBMET01854 0.178 0.022 DBMET01855 0.129 0.049 DBMET01856 | DBMET01855 | |
| 0.034 | 0.028 | 0.034 | AMPA receptor agonist | |||
| 0.089 | 0.084 | 0.154 | Cyclin-dependent kinase 2 inhibitor | 0.154 0.036 DBMET01854 0.098 0.072 DBMET01856 | DBMET01854 | |
| 0.081 | 0.078 | 0.111 | CDK2/cyclin A inhibitor | 0.111 0.049 DBMET01854 | DBMET01854 | |
| 0.071 | 0.077 | 0.084 | AXL receptor tyrosine kinase inhibitor | 0.084 0.055 DBMET01855 | DBMET01855 | |
| 0.049 | 0.058 | 0.067 | Tyk2 inhibitor | 0.067 0.043 DBMET01855 | DBMET01855 | |
| 0.026 | 0.036 | 0.036 | LIM domain kinase 2 inhibitor | 0.036 0.013 DBMET01855 | DBMET01855 | |
| 0.045 | 0.055 | 0.069 | Cyclin B inhibitor | 0.069 0.022 DBMET01854 0.06 0.031 DBMET01855 0.058 0.034 DBMET01856 | DBMET01854 | |
| 0.054 | 0.076 | 0.145 | Janus tyrosine kinase 2 inhibitor | 0.074 0.052 DBMET01854 0.145 0.021 DBMET01855 0.064 0.062 DBMET01856 | DBMET01855 | |
| 0.062 | 0.086 | 0.112 | ALK inhibitor | 0.112 0.034 DBMET01855 | DBMET01855 | |
| 0.034 | 0.063 | 0.083 | Janus tyrosine kinase 1 inhibitor | 0.083 0.028 DBMET01855 | DBMET01855 | |
| 0.111 | 0.144 | 0.308 | TRKC antagonist | 0.307 0.025 DBMET01854 0.234 0.054 DBMET01855 0.308 0.025 DBMET01856 | DBMET01856 | |
| 0.027 | 0.064 | 0.049 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.049 0.033 DBMET01854 0.049 0.033 DBMET01855 0.043 0.039 DBMET01856 | DBMET01855 | |
| 0.125 | 0.163 | 0.661 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.263 0.062 DBMET01854 0.661 0.005 DBMET01855 0.346 0.036 DBMET01856 | DBMET01855 | |
| 0.073 | 0.112 | 0.29 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.193 0.03 DBMET01854 0.29 0.012 DBMET01855 0.21 0.026 DBMET01856 | DBMET01855 | |
| 0.073 | 0.112 | 0.29 | Abl kinase inhibitor | 0.192 0.03 DBMET01854 0.29 0.012 DBMET01855 0.21 0.026 DBMET01856 | DBMET01855 | |
| 0.049 | 0.091 | 0.141 | Protein kinase B alpha inhibitor | 0.123 0.017 DBMET01854 0.141 0.011 DBMET01855 0.118 0.019 DBMET01856 | DBMET01855 | |
| 0.038 | 0.08 | 0.146 | p38 MAP kinase inhibitor | 0.091 0.036 DBMET01854 0.146 0.02 DBMET01856 | DBMET01856 | |
| 0.064 | 0.107 | 0.275 | Check point kinase 2 inhibitor | 0.174 0.024 DBMET01854 0.275 0.008 DBMET01855 0.21 0.015 DBMET01856 | DBMET01855 | |
| 0.062 | 0.111 | 0.122 | Protein kinase C delta inhibitor | 0.09 0.063 DBMET01854 0.122 0.036 DBMET01856 | DBMET01856 | |
| 0.122 | 0.173 | 0.651 | Dyrk kinase inhibitor | 0.264 0.066 DBMET01854 0.651 0.005 DBMET01855 0.342 0.039 DBMET01856 | DBMET01855 | |
| 0.051 | 0.102 | 0.131 | Protein kinase B gamma inhibitor | 0.083 0.044 DBMET01854 0.131 0.022 DBMET01855 0.088 0.04 DBMET01856 | DBMET01855 | |
| 0.074 | 0.127 | 0.152 | Cyclin-dependent kinase inhibitor | 0.152 0.055 DBMET01854 0.104 0.086 DBMET01856 | DBMET01854 | |
| 0.05 | 0.103 | 0.139 | MAP kinase 10 inhibitor | 0.096 0.037 DBMET01854 0.139 0.018 DBMET01855 0.115 0.027 DBMET01856 | DBMET01855 | |
| 0.012 | 0.081 | 0.019 | Somatostatin 3 agonist | 0.019 0.012 DBMET01855 | DBMET01855 | |
| 0.035 | 0.109 | 0.055 | Cannabinoid CB1 receptor antagonist | 0.055 0.052 DBMET01856 | DBMET01856 | |
| 0.056 | 0.132 | 0.106 | Hepatocyte growth factor antagonist | 0.094 0.058 DBMET01854 0.106 0.046 DBMET01855 0.085 0.069 DBMET01856 | DBMET01855 | |
| 0.059 | 0.137 | 0.141 | Cyclin-dependent kinase 5 inhibitor | 0.141 0.045 DBMET01855 0.102 0.073 DBMET01856 | DBMET01855 | |
| 0.042 | 0.125 | 0.151 | MAP3K7 inhibitor | 0.087 0.032 DBMET01854 0.151 0.01 DBMET01855 0.098 0.023 DBMET01856 | DBMET01855 | |
| 0.08 | 0.163 | 0.114 | Interleukin 8 antagonist | 0.114 0.069 DBMET01855 | DBMET01855 | |
| 0.02 | 0.105 | 0.057 | Cyclin E inhibitor | 0.057 0.043 DBMET01854 | DBMET01854 | |
| 0.006 | 0.097 | 0.043 | Alpha 2c adrenoreceptor agonist | 0.043 0.004 DBMET01855 | DBMET01855 | |
| 0.065 | 0.16 | 0.166 | Interleukin 1b antagonist | 0.114 0.067 DBMET01854 0.166 0.03 DBMET01856 | DBMET01856 | |
| 0.045 | 0.142 | 0.132 | Aurora-A kinase inhibitor | 0.084 0.08 DBMET01854 0.132 0.048 DBMET01855 | DBMET01855 | |
| 0.171 | 0.27 | 0.254 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.207 0.145 DBMET01854 0.254 0.061 DBMET01855 0.225 0.106 DBMET01856 | DBMET01855 | |
| 0.007 | 0.108 | 0.016 | CDK2/cyclin A3 inhibitor | 0.016 0.011 DBMET01854 | DBMET01854 | |
| 0.074 | 0.177 | 0.321 | CDC-like kinase 1 inhibitor | 0.198 0.037 DBMET01854 0.321 0.008 DBMET01855 0.245 0.019 DBMET01856 | DBMET01855 | |
| 0.005 | 0.109 | 0.054 | Alpha 2a adrenoreceptor agonist | 0.054 0.004 DBMET01855 | DBMET01855 | |
| 0.061 | 0.177 | 0.095 | Transforming growth factor beta 3 antagonist | 0.095 0.03 DBMET01854 0.089 0.04 DBMET01855 0.087 0.044 DBMET01856 | DBMET01854 | |
| 0.036 | 0.156 | 0.145 | Rho-associated kinase II inhibitor | 0.067 0.06 DBMET01854 0.145 0.018 DBMET01855 0.066 0.062 DBMET01856 | DBMET01855 | |
| 0.058 | 0.179 | 0.344 | Vascular endothelial growth factor 3 antagonist | 0.193 0.045 DBMET01854 0.344 0.014 DBMET01855 0.204 0.04 DBMET01856 | DBMET01855 | |
| 0.057 | 0.18 | 0.194 | TRKA antagonist | 0.194 0.032 DBMET01854 0.103 0.085 DBMET01855 0.183 0.035 DBMET01856 | DBMET01854 | |
| 0.047 | 0.173 | 0.126 | Glycogen synthase kinase-3 beta inhibitor | 0.107 0.071 DBMET01854 0.126 0.057 DBMET01855 0.109 0.069 DBMET01856 | DBMET01855 | |
| 0.029 | 0.156 | 0.051 | Fatty acid synthase inhibitor | 0.051 0.049 DBMET01855 | DBMET01855 | |
| 0.026 | 0.154 | 0.143 | CDC7 inhibitor | 0.094 0.027 DBMET01854 0.143 0.011 DBMET01855 0.099 0.024 DBMET01856 | DBMET01855 | |
| 0.04 | 0.17 | 0.074 | Transforming growth factor antagonist | 0.074 0.042 DBMET01854 0.068 0.05 DBMET01855 0.065 0.056 DBMET01856 | DBMET01854 | |
| 0.048 | 0.179 | 0.176 | Vascular endothelial growth factor antagonist | 0.124 0.066 DBMET01854 0.176 0.045 DBMET01856 | DBMET01856 | |
| 0.092 | 0.223 | 0.149 | Interleukin 6 antagonist | 0.139 0.107 DBMET01854 0.149 0.091 DBMET01856 | DBMET01856 | |
| 0.047 | 0.179 | 0.122 | Glycogen synthase kinase-3 inhibitor | 0.105 0.075 DBMET01854 0.122 0.06 DBMET01855 0.109 0.07 DBMET01856 | DBMET01855 | |
| 0.07 | 0.204 | 0.208 | Interleukin 1 antagonist | 0.165 0.049 DBMET01854 0.208 0.03 DBMET01856 | DBMET01856 | |
| 0.045 | 0.184 | 0.15 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.15 0.014 DBMET01855 | DBMET01855 | |
| 0.038 | 0.177 | 0.135 | I kappa B kinase inhibitor | 0.126 0.024 DBMET01854 0.109 0.032 DBMET01855 0.135 0.02 DBMET01856 | DBMET01856 | |
| 0.055 | 0.194 | 0.203 | Protein kinase C gamma inhibitor | 0.203 0.013 DBMET01855 0.102 0.073 DBMET01856 | DBMET01855 | |
| 0.076 | 0.219 | 0.219 | Protein kinase (CK1) gamma 3 inhibitor | 0.18 0.061 DBMET01854 0.219 0.038 DBMET01855 0.189 0.054 DBMET01856 | DBMET01855 | |
| 0.048 | 0.193 | 0.23 | Glycogen synthase kinase-3 alpha inhibitor | 0.128 0.079 DBMET01854 0.23 0.033 DBMET01855 0.172 0.052 DBMET01856 | DBMET01855 | |
| 0.176 | 0.321 | 0.444 | Calcium channel L-type activator | 0.4 0.081 DBMET01854 0.444 0.054 DBMET01856 | DBMET01856 | |
| 0.061 | 0.21 | 0.139 | Src kinase inhibitor | 0.139 0.091 DBMET01855 | DBMET01855 | |
| 0.012 | 0.161 | 0.058 | Alpha 1d adrenoreceptor agonist | 0.058 0.012 DBMET01855 | DBMET01855 | |
| 0.056 | 0.205 | 0.221 | Tyrosine-protein kinase receptor antagonist | 0.221 0.033 DBMET01854 0.212 0.036 DBMET01856 | DBMET01854 | |
| 0.036 | 0.187 | 0.145 | Vascular endothelial growth factor 2 antagonist | 0.098 0.073 DBMET01854 0.145 0.05 DBMET01856 | DBMET01856 | |
| 0.059 | 0.211 | 0.151 | Activin receptor-like kinase 4 inhibitor | 0.151 0.028 DBMET01854 0.126 0.045 DBMET01855 0.151 0.028 DBMET01856 | DBMET01856 | |
| 0.021 | 0.175 | 0.077 | Transforming growth factor beta 1 antagonist | 0.077 0.016 DBMET01854 0.061 0.025 DBMET01855 0.064 0.023 DBMET01856 | DBMET01854 | |
| 0.033 | 0.191 | 0.102 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.094 0.083 DBMET01854 0.102 0.078 DBMET01856 | DBMET01856 | |
| 0.084 | 0.245 | 0.54 | Aldehyde oxidase inhibitor | 0.54 0.027 DBMET01855 | DBMET01855 | |
| 0.153 | 0.314 | 0.252 | MAP kinase kinase 3 inhibitor | 0.238 0.044 DBMET01854 0.219 0.076 DBMET01855 0.252 0.029 DBMET01856 | DBMET01856 | |
| 0.05 | 0.212 | 0.125 | TRKB antagonist | 0.123 0.069 DBMET01854 0.125 0.067 DBMET01856 | DBMET01856 | |
| 0.006 | 0.175 | 0.042 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.042 0.012 DBMET01855 | DBMET01855 | |
| 0.042 | 0.219 | 0.168 | Protein kinase (CK1) inhibitor | 0.15 0.067 DBMET01854 0.108 0.102 DBMET01855 0.168 0.055 DBMET01856 | DBMET01856 | |
| 0.026 | 0.206 | 0.123 | Platelet growth factor antagonist | 0.083 0.054 DBMET01854 0.123 0.028 DBMET01855 0.096 0.043 DBMET01856 | DBMET01855 | |
| 0.037 | 0.219 | 0.124 | c-Src kinase inhibitor | 0.124 0.072 DBMET01855 | DBMET01855 | |
| 0.05 | 0.232 | 0.118 | Cyclin-dependent kinase 7 inhibitor | 0.118 0.086 DBMET01855 | DBMET01855 | |
| 0.059 | 0.242 | 0.091 | Hedgehog signaling inhibitor | 0.091 0.083 DBMET01855 | DBMET01855 | |
| 0.016 | 0.205 | 0.029 | DNA topoisomerase IV inhibitor | 0.029 0.023 DBMET01854 0.028 0.026 DBMET01856 | DBMET01854 | |
| 0.015 | 0.206 | 0.069 | Fibroblast growth factor 4 antagonist | 0.069 0.028 DBMET01855 | DBMET01855 | |
| 0.029 | 0.223 | 0.103 | Protein kinase B beta inhibitor | 0.075 0.049 DBMET01854 0.103 0.024 DBMET01855 0.081 0.041 DBMET01856 | DBMET01855 | |
| 0.057 | 0.256 | 0.145 | CDC-like kinase 3 inhibitor | 0.095 0.091 DBMET01854 0.145 0.021 DBMET01855 0.103 0.072 DBMET01856 | DBMET01855 | |
| 0.048 | 0.249 | 0.123 | Growth factor antagonist | 0.118 0.094 DBMET01854 0.123 0.089 DBMET01855 | DBMET01855 | |
| 0.049 | 0.252 | 0.217 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.119 0.085 DBMET01854 0.217 0.041 DBMET01855 0.136 0.073 DBMET01856 | DBMET01855 | |
| 0.047 | 0.252 | 0.154 | Protein kinase (CK1) gamma 2 inhibitor | 0.125 0.062 DBMET01854 0.154 0.047 DBMET01855 0.138 0.054 DBMET01856 | DBMET01855 | |
| 0.023 | 0.235 | 0.077 | Protein kinase C alpha inhibitor | 0.061 0.059 DBMET01854 0.077 0.036 DBMET01855 0.068 0.047 DBMET01856 | DBMET01855 | |
| 0.05 | 0.269 | 0.142 | Activin receptor-like kinase 2 inhibitor | 0.142 0.074 DBMET01855 | DBMET01855 | |
| 0.058 | 0.289 | 0.242 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.131 0.113 DBMET01854 0.242 0.051 DBMET01855 0.155 0.091 DBMET01856 | DBMET01855 | |
| 0.022 | 0.255 | 0.056 | I kappa B kinase 2 inhibitor | 0.056 0.054 DBMET01854 | DBMET01854 | |
| 0.018 | 0.252 | 0.159 | MAP kinase 11 inhibitor | 0.115 0.028 DBMET01854 0.159 0.015 DBMET01856 | DBMET01856 | |
| 0.022 | 0.259 | 0.165 | Protein kinase (CK1) delta inhibitor | 0.145 0.056 DBMET01854 0.165 0.044 DBMET01856 | DBMET01856 | |
| 0.035 | 0.275 | 0.115 | Tubulin antagonist | 0.115 0.084 DBMET01856 | DBMET01856 | |
| 0.148 | 0.392 | 0.322 | MAP kinase kinase 6 inhibitor | 0.276 0.16 DBMET01854 0.322 0.115 DBMET01855 0.322 0.115 DBMET01856 | DBMET01856 | |
| 0.061 | 0.308 | 0.142 | Antimitotic | 0.142 0.129 DBMET01856 | DBMET01856 | |
| 0.034 | 0.286 | 0.115 | HIV-1 integrase (Overall Integration) inhibitor | 0.101 0.054 DBMET01854 0.115 0.042 DBMET01856 | DBMET01856 | |
| 0.027 | 0.283 | 0.119 | RET inhibitor | 0.119 0.08 DBMET01855 0.101 0.095 DBMET01856 | DBMET01855 | |
| 0.035 | 0.311 | 0.219 | Ribosomal protein S6 kinase inhibitor | 0.219 0.03 DBMET01855 | DBMET01855 | |
| 0.107 | 0.383 | 0.183 | ErbB-1 antagonist | 0.183 0.111 DBMET01854 0.177 0.12 DBMET01856 | DBMET01854 | |
| 0.007 | 0.289 | 0.03 | Catechol O-methyltransferase inhibitor | 0.03 0.028 DBMET01855 | DBMET01855 | |
| 0.021 | 0.314 | 0.516 | Pim-1 kinase inhibitor | 0.108 0.051 DBMET01854 0.516 0.004 DBMET01855 0.116 0.045 DBMET01856 | DBMET01855 | |
| 0.05 | 0.345 | 0.135 | Interleukin antagonist | 0.135 0.131 DBMET01856 | DBMET01856 | |
| 0.022 | 0.327 | 0.104 | Aryl hydrocarbon receptor antagonist | 0.081 0.026 DBMET01854 0.104 0.012 DBMET01855 0.078 0.029 DBMET01856 | DBMET01855 | |
| 0.042 | 0.348 | 0.174 | Aldehyde dehydrogenase inhibitor | 0.174 0.036 DBMET01855 | DBMET01855 | |
| 0.005 | 0.323 | 0.044 | Alpha 2b adrenoreceptor agonist | 0.044 0.004 DBMET01855 | DBMET01855 | |
| 0.046 | 0.368 | 0.192 | Cyclin-dependent kinase 8 inhibitor | 0.154 0.075 DBMET01854 0.192 0.041 DBMET01855 0.172 0.059 DBMET01856 | DBMET01855 | |
| 0.013 | 0.339 | 0.113 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.113 0.029 DBMET01855 | DBMET01855 | |
| 0.027 | 0.354 | 0.065 | Exportin-1 inhibitor | 0.065 0.056 DBMET01855 | DBMET01855 | |
| 0.034 | 0.367 | 0.088 | Bromodomain-containing protein 2 inhibitor | 0.088 0.059 DBMET01855 | DBMET01855 | |
| 0.017 | 0.359 | 0.082 | Botulinum neurotoxin type A inhibitor | 0.082 0.016 DBMET01855 | DBMET01855 | |
| 0.015 | 0.361 | 0.054 | Purinergic P2X4 antagonist | 0.054 0.02 DBMET01855 | DBMET01855 | |
| 0.009 | 0.366 | 0.153 | Benzodiazepine agonist | 0.099 0.026 DBMET01854 0.153 0.007 DBMET01855 0.089 0.032 DBMET01856 | DBMET01855 | |
| 0.075 | 0.432 | 0.196 | MAP-kinase-activated kinase 5 inhibitor | 0.196 0.108 DBMET01855 | DBMET01855 | |
| 0.006 | 0.367 | 0.05 | Tyrosine-protein kinase EMT inhibitor | 0.05 0.046 DBMET01855 | DBMET01855 | |
| 0.022 | 0.39 | 0.231 | Protein kinase C mu inhibitor | 0.231 0.009 DBMET01855 | DBMET01855 | |
| 0.004 | 0.379 | 0.031 | Imidazoline I1 receptor antagonist | 0.031 0.007 DBMET01855 | DBMET01855 | |
| 0.009 | 0.389 | 0.066 | Dopamine D3 antagonist | 0.066 0.04 DBMET01855 | DBMET01855 | |
| 0.048 | 0.431 | 0.166 | Polo-like kinase-3 inhibitor | 0.166 0.068 DBMET01855 | DBMET01855 | |
| 0.01 | 0.395 | 0.084 | Diacylglycerol O-acyltransferase inhibitor | 0.053 0.032 DBMET01854 0.084 0.012 DBMET01855 0.056 0.029 DBMET01856 | DBMET01855 | |
| 0.017 | 0.403 | 0.113 | Protein-tyrosine kinase Lyn inhibitor | 0.113 0.09 DBMET01855 | DBMET01855 | |
| 0.015 | 0.408 | 0.088 | MAP-kinase-activated kinase 2 inhibitor | 0.088 0.036 DBMET01855 | DBMET01855 | |
| 0.02 | 0.414 | 0.104 | MAP-kinase-activated kinase inhibitor | 0.104 0.036 DBMET01855 | DBMET01855 | |
| 0.025 | 0.423 | 0.215 | GABA receptor agonist | 0.144 0.039 DBMET01854 0.215 0.015 DBMET01855 0.122 0.055 DBMET01856 | DBMET01855 | |
| 0.006 | 0.406 | 0.037 | Calcium release-activated channel blocker | 0.037 0.018 DBMET01855 | DBMET01855 | |
| 0.051 | 0.467 | 0.187 | Focal adhesion kinase 2 inhibitor | 0.187 0.08 DBMET01855 | DBMET01855 | |
| 0.054 | 0.48 | 0.534 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.534 0.004 DBMET01855 0.154 0.139 DBMET01856 | DBMET01855 | |
| 0.06 | 0.486 | 0.155 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.155 0.125 DBMET01855 | DBMET01855 | |
| 0.009 | 0.436 | 0.106 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.106 0.032 DBMET01855 | DBMET01855 | |
| 0.012 | 0.451 | 0.348 | CYP2A6 inhibitor | 0.348 0.003 DBMET01855 | DBMET01855 | |
| 0.011 | 0.462 | 0.142 | Purinergic P2X2 antagonist | 0.142 0.013 DBMET01855 | DBMET01855 | |
| 0.047 | 0.51 | 0.156 | MAP kinase 3 inhibitor | 0.131 0.106 DBMET01854 0.156 0.058 DBMET01855 0.146 0.075 DBMET01856 | DBMET01855 | |
| 0.004 | 0.469 | 0.075 | AMPA receptor antagonist | 0.075 0.019 DBMET01855 | DBMET01855 | |
| 0.005 | 0.472 | 0.202 | Pim-2 kinase inhibitor | 0.063 0.028 DBMET01854 0.202 0.005 DBMET01855 0.059 0.031 DBMET01856 | DBMET01855 | |
| 0.005 | 0.479 | 0.101 | GABA A receptor antagonist | 0.101 0.016 DBMET01855 | DBMET01855 | |
| 0.006 | 0.48 | 0.045 | Histamine H1 receptor agonist | 0.045 0.027 DBMET01855 | DBMET01855 | |
| 0.014 | 0.493 | 0.132 | GABA A receptor agonist | 0.132 0.02 DBMET01855 | DBMET01855 | |
| 0.009 | 0.491 | 0.295 | Protein kinase C zeta inhibitor | 0.153 0.019 DBMET01854 0.295 0.005 DBMET01855 0.179 0.014 DBMET01856 | DBMET01855 | |
| 0.008 | 0.492 | 0.278 | Pim-3 kinase inhibitor | 0.104 0.041 DBMET01854 0.278 0.004 DBMET01855 0.106 0.04 DBMET01856 | DBMET01855 | |
| 0.009 | 0.505 | 0.102 | Granulocyte macrophage colony stimulating factor antagonist | 0.102 0.069 DBMET01855 | DBMET01855 | |
| 0.067 | 0.564 | 0.247 | Caspase 3 stimulant | 0.247 0.115 DBMET01855 | DBMET01855 | |
| 0.005 | 0.511 | 0.099 | GABA receptor antagonist | 0.099 0.016 DBMET01855 | DBMET01855 | |
| 0.062 | 0.582 | 0.499 | GABA C receptor rho-3 antagonist | 0.343 0.09 DBMET01854 0.499 0.026 DBMET01855 0.351 0.085 DBMET01856 | DBMET01855 | |
| 0.038 | 0.559 | 0.087 | Glutamate release inhibitor | 0.087 0.07 DBMET01856 | DBMET01856 | |
| 0.107 | 0.634 | 0.632 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.298 0.215 DBMET01854 0.632 0.005 DBMET01855 0.35 0.151 DBMET01856 | DBMET01855 | |
| 0.007 | 0.535 | 0.046 | Protein kinase (CK2) beta inhibitor | 0.046 0.009 DBMET01855 | DBMET01855 | |
| 0.014 | 0.55 | 0.456 | Aryl hydrocarbon receptor agonist | 0.251 0.078 DBMET01854 0.456 0.029 DBMET01855 0.291 0.064 DBMET01856 | DBMET01855 | |
| 0.005 | 0.545 | 0.108 | TRPA1 antagonist | 0.108 0.016 DBMET01855 | DBMET01855 | |
| 0.061 | 0.603 | 0.319 | Calcium channel activator | 0.219 0.186 DBMET01854 0.233 0.168 DBMET01855 0.319 0.074 DBMET01856 | DBMET01856 | |
| 0.004 | 0.546 | 0.111 | Dopamine D4 antagonist | 0.111 0.023 DBMET01855 | DBMET01855 | |
| 0.016 | 0.567 | 0.126 | Beta glucuronidase inhibitor | 0.126 0.04 DBMET01855 | DBMET01855 | |
| 0.086 | 0.658 | 0.187 | 5 Hydroxytryptamine 3E antagonist | 0.187 0.088 DBMET01855 | DBMET01855 | |
| 0.006 | 0.584 | 0.069 | Sphingosine 1-phosphate receptor 4 agonist | 0.069 0.045 DBMET01855 | DBMET01855 | |
| 0.01 | 0.589 | 0.067 | Pregnane X receptor antagonist | 0.067 0.018 DBMET01855 | DBMET01855 | |
| 0.011 | 0.593 | 0.047 | Glutamate (mGluR4) antagonist | 0.047 0.024 DBMET01855 | DBMET01855 | |
| 0.013 | 0.618 | 0.113 | 5 Hydroxytryptamine 3A agonist | 0.111 0.064 DBMET01854 0.113 0.062 DBMET01855 0.102 0.074 DBMET01856 | DBMET01855 | |
| 0.004 | 0.617 | 0.024 | Thymidine phosphorylase inhibitor | 0.024 0.023 DBMET01855 | DBMET01855 | |
| 0.029 | 0.649 | 0.248 | Neurotrophic factor enhancer | 0.248 0.04 DBMET01855 | DBMET01855 | |
| 0.016 | 0.651 | 0.248 | Heat shock protein 90 antagonist | 0.248 0.021 DBMET01855 | DBMET01855 | |
| 0.004 | 0.655 | 0.101 | GABA B receptor antagonist | 0.101 0.005 DBMET01855 | DBMET01855 | |
| 0.007 | 0.661 | 0.066 | Protein kinase C beta inhibitor | 0.066 0.056 DBMET01855 | DBMET01855 | |
| 0.003 | 0.671 | 0.106 | Protein kinase (CK2) alpha inhibitor | 0.106 0.071 DBMET01855 | DBMET01855 | |
| 0.003 | 0.675 | 0.041 | Dihydrofolate reductase inhibitor | 0.041 0.038 DBMET01855 | DBMET01855 | |
| 0.009 | 0.681 | 0.158 | Anticonvulsant | 0.158 0.119 DBMET01855 | DBMET01855 | |
| 0.009 | 0.687 | 0.092 | 5 Hydroxytryptamine 3 agonist | 0.092 0.019 DBMET01855 | DBMET01855 | |
| 0.011 | 0.688 | 0.181 | I kappa B kinase epsilon inhibitor | 0.151 0.118 DBMET01854 0.181 0.088 DBMET01855 0.155 0.114 DBMET01856 | DBMET01855 | |
| 0.02 | 0.7 | 0.173 | GABA C receptor rho-2 antagonist | 0.173 0.048 DBMET01855 | DBMET01855 | |
| 0.003 | 0.684 | 0.124 | Protein kinase (CK2) inhibitor | 0.124 0.046 DBMET01855 | DBMET01855 | |
| 0.034 | 0.721 | 0.268 | Apoptosis agonist | 0.268 0.197 DBMET01855 | DBMET01855 | |
| 0.01 | 0.703 | 0.048 | Glucose-6-phosphate translocase inhibitor | 0.048 0.044 DBMET01855 | DBMET01855 | |
| 0.045 | 0.738 | 0.483 | Caspase 9 stimulant | 0.483 0.067 DBMET01855 | DBMET01855 | |
| 0.034 | 0.761 | 0.324 | 5 Hydroxytryptamine release inhibitor | 0.324 0.139 DBMET01855 | DBMET01855 | |
| 0.013 | 0.762 | 0.138 | TRPA1 agonist | 0.138 0.04 DBMET01855 | DBMET01855 | |
| 0.008 | 0.758 | 0.129 | Heat shock protein 90 alpha antagonist | 0.129 0.113 DBMET01855 | DBMET01855 | |
| 0.02 | 0.771 | 0.129 | Transcription factor STAT6 inhibitor | 0.129 0.046 DBMET01855 | DBMET01855 | |
| 0.019 | 0.802 | 0.128 | CF transmembrane conductance regulator agonist | 0.128 0.122 DBMET01855 | DBMET01855 | |
| 0.002 | 0.795 | 0.04 | Inosine monophosphate dehydrogenase inhibitor | 0.04 0.021 DBMET01855 | DBMET01855 | |
| 0.007 | 0.805 | 0.121 | Toll-Like receptor antagonist | 0.121 0.083 DBMET01855 | DBMET01855 | |
| 0.01 | 0.81 | 0.181 | DNA damaging | 0.181 0.133 DBMET01855 | DBMET01855 | |
| 0.015 | 0.822 | 0.186 | 3C-like protease (Human coronavirus) inhibitor | 0.186 0.06 DBMET01855 | DBMET01855 | |
| 0.009 | 0.847 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.057 DBMET01855 | DBMET01855 | |
| 0.003 | 0.845 | 0.063 | Histidine decarboxylase inhibitor | 0.063 0.058 DBMET01855 | DBMET01855 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |